抗血小板治疗:血小板糖蛋白IIb/IIIa拮抗剂的最新进展。

Mousa
{"title":"抗血小板治疗:血小板糖蛋白IIb/IIIa拮抗剂的最新进展。","authors":"Mousa","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.</p>","PeriodicalId":80270,"journal":{"name":"Current interventional cardiology reports","volume":"1 3","pages":"243-252"},"PeriodicalIF":0.0000,"publicationDate":"1999-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists.\",\"authors\":\"Mousa\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.</p>\",\"PeriodicalId\":80270,\"journal\":{\"name\":\"Current interventional cardiology reports\",\"volume\":\"1 3\",\"pages\":\"243-252\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current interventional cardiology reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current interventional cardiology reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

本文综述了抗血小板治疗的最新进展,比较了各种抗血小板策略与血小板糖蛋白(GP) IIb/IIIa受体拮抗剂的抗血小板/抗血栓疗效,并讨论了长期抗GP IIb/IIIa治疗的发展问题,以及与GP IIb/IIIa拮抗剂的潜在辅助策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antiplatelet Therapies: Recent Advances in the Development of Platelet Glycoprotein IIb/IIIa Antagonists.

This article reviews recent advances in antiplatelet therapies, compares the antiplatelet/antithrombotic efficacy of various antiplatelet strategies to that of platelet glycoprotein (GP) IIb/IIIa receptor antagonists, and discusses issues in the development of long-term anti-GP IIb/IIIa therapy, and the potential adjunct strategies with GP IIb/IIIa antagonists.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信